Cell Therapy Media Market

Table Of Contents

1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Context and Background
3.2. Introduction to Cell Therapies
3.3. Comparison of Cell Therapies with Other Biopharmaceuticals
3.4. Classification of Cell Therapy Products
3.5. Overview of Cell Therapy Development and Manufacturing
3.6. Role of Raw Materials in Cell Therapy Development and Manufacturing
3.7. Types of Cell Therapy Consumables
3.8. Key Challenges Associated with Manufacturing of Cell Therapy Consumables
3.9. Future Perspectives

4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. List of Cell Therapy Kit Providers
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Location of Kit Manufacturing Facilities
4.2.5. Analysis by Certifications / Accreditations Received
4.2.6. Analysis by Type of End-User
4.2.7. Analysis by Type of Cell Therapy
4.2.8. Analysis by Type of Function
4.2.9. Analysis by Kit Components
4.2.10. Analysis by Storage Temperature
4.2.11. Analysis by Scale of Operation
4.2.12. Analysis by Application Area
4.2.13. Analysis by Application Area and Geography

4.3. List of Cell Therapy Media Providers
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Location of Headquarters
4.3.4. Analysis by Location of Media Manufacturing Facilities
4.3.5. Analysis by Certifications / Accreditations Received
4.3.6. Analysis by Type of End-User
4.3.7. Analysis by Type of Cell Therapy
4.3.8. Analysis by Media Compatibility
4.3.9. Analysis by Type of Function
4.3.10. Analysis by Storage Temperature
4.3.11. Analysis by Volume of Media
4.3.12. Analysis by Scale of Operation
4.3.13. Analysis by Application Area
4.3.14. Analysis by Application Area and Geography

4.4. List of Cell Therapy Reagent Providers
4.4.1. Analysis by Year of Establishment
4.4.2. Analysis by Company Size
4.4.3. Analysis by Location of Headquarters
4.4.4. Analysis by Location of Reagent Manufacturing Facilities
4.4.5. Analysis by Certifications / Accreditations Received
4.4.6. Analysis by Type of End-User
4.4.7. Analysis by Type of Cell Therapy
4.4.8. Analysis by Type of Function
4.4.9. Analysis by Storage Temperature
4.4.10. Analysis by Volume of Reagent
4.4.11. Analysis by Scale of Operation
4.4.12. Analysis by Application Area
4.4.13. Analysis by Application Area and Geography

4.5. List of Cell Therapy Extracellular Matrix Providers
4.5.1. Analysis by Year of Establishment
4.5.2. Analysis by Company Size
4.5.3. Analysis by Location of Headquarters
4.5.4. Analysis by Location of Extracellular Matrix Manufacturing Facilities
4.5.5. Analysis by Certifications / Accreditations Received
4.5.6. Analysis by Type of End-User
4.5.7. Analysis by Type of Stem Cell Therapy
4.5.8. Analysis by Type of Function
4.5.9. Analysis by Type of ECM Coating
4.5.10. Analysis by Type of Formulation
4.5.11. Analysis by Shelf Life
4.5.12. Analysis by Storage Temperature
4.5.13. Analysis by Volume of Extracellular Matrix
4.5.14. Analysis by Scale of Operation
4.5.15. Analysis by Application Area
4.5.16. Analysis by Application Area and Geography

5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Key Assumptions and Parameters
5.3. Methodology
5.4. Cell Therapy Consumable Providers: Company Competitiveness Analysis
5.5. Cell Therapy Kits Providers
5.6. Cell Therapy Media Providers
5.6.1. Cell Therapy Media Providers based in North America
5.6.2. Cell Therapy Media Providers based in Europe
5.6.3. Cell Therapy Media Providers based in Asia-Pacific

5.7. Cell Therapy Reagent Providers
5.8. Cell Therapy Extracellular Matrix Providers

6. BRAND POSITIONING OF KEY INDUSTRY PLAYERS
6.1. Chapter Overview
6.2. Scope and Methodology
6.3. Brand Positioning: STEMCELL Technologies
6.4. Brand Positioning: Miltenyi Biotec
6.5. Brand Positioning: Thermo Fisher Scientific
6.6. Brand Positioning: Takara Bio
6.7. Brand Positioning: GeminiBio

7. COMPANY PROFILES
7.1. Chapter Overview
7.2. STEMCELL Technologies
7.2.1. Company Overview
7.2.2. Product Portfolio
7.2.3. Recent Developments and Future Outlook

7.3. Miltenyi Biotec
7.3.1. Company Overview
7.3.2. Product Portfolio
7.3.3. Recent Developments and Future Outlook

7.4. Thermo Fisher Scientific
7.4.1. Company Overview
7.4.2. Product Portfolio
7.4.3. Recent Developments and Future Outlook

7.5. Bio-Techne
7.5.1. Company Overview
7.5.2. Product Portfolio
7.5.3. Recent Developments and Future Outlook

7.6. Irvine Scientific
7.6.1. Company Overview
7.6.2. Product Portfolio
7.6.3. Recent Developments and Future Outlook

7.7. Lonza
7.7.1. Company Overview
7.7.2. Product Portfolio
7.7.3. Recent Developments and Future Outlook

7.8. Sartorius
7.8.1. Company Overview
7.8.2. Product Portfolio
7.8.3. Recent Developments and Future Outlook

7.9. BD Biosciences
7.9.1. Company Overview
7.9.2. Product Portfolio
7.9.3. Recent Developments and Future Outlook

7.10. Corning
7.10.1. Company Overview
7.10.2. Product Portfolio
7.10.3. Recent Developments and Future Outlook

7.11. CellGenix
7.11.1. Company Overview
7.11.2. Product Portfolio
7.11.3. Recent Developments and Future Outlook

8. RECENT DEVELOPMENTS AND INITIATIVES
8.1. Chapter Overview
8.2. Partnership Models

8.3. Cell Therapy Consumables: Partnerships and Collaborations
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Year and Type of Partnership
8.3.4. Analysis by Type of Product
8.3.5. Analysis by Type of Partnership and Type of Product
8.3.6. Analysis by Type of Cell Therapy
8.3.7. Analysis by Type of Product and Type of Cell Therapy
8.3.8. Most Active Players: Analysis by Number of Partnerships
8.3.9. Analysis by Region
8.3.9.1. Intercontinental and Intracontinental Agreements
8.3.9.2. Local and International Agreements

8.4. Cell Therapy Consumables: Mergers and Acquisitions
8.4.1. Cumulative Year-wise Trend of Mergers and Acquisitions
8.4.2. Analysis by Type of Agreement
8.4.3. Analysis by Key Value Drivers
8.4.4. Analysis by Year of Acquisition and Key Value Drivers

8.5. Cell Therapy Consumables: Recent Expansions
8.5.1. Analysis by Year of Expansion
8.5.2. Analysis by Type of Expansion
8.5.3. Analysis by Year and Type of Expansion
8.5.4. Analysis by Type of Product
8.5.5. Analysis by Type of Expansion and Type of Product
8.5.6. Analysis by Area of Expansion
8.5.7. Most Active Players: Analysis by Number of Expansions
8.5.8. Analysis by Region
8.5.8.1. Analysis by Location of Facility (Continent-wise)
8.5.8.2. Analysis by Location of Facility (Country-wise)
8.5.9. Analysis by Type of Expansion and Location of Facility

9. LIKELY PARTNER ANALYSIS FOR CELL THERAPY CONSUMABLE PROVIDERS
9.1. Chapter Overview
9.2. Scoring Criteria and Key Assumptions
9.3. Scope and Methodology
9.4. Key Potential Strategic Partners for Cell Therapy Consumable Providers
9.4.1. Likely Partners for Dendritic Cell Therapy Consumable Providers
9.4.2. Likely Partners for NK Cell Therapy Consumable Providers
9.4.3. Likely Partners for Stem Cell Therapy Consumable Providers
9.4.4. Likely Partners for T-Cell Therapy Consumable Providers

10. ROOTS ANALYSIS PRICING STRATEGY
10.1. Chapter Overview
10.2. Roots Analysis Framework
10.2.1. Theoretical Framework and Price Evaluation Hypothesis for Cell Therapy Media
10.2.1.1. Methodology
10.2.1.2. Results and Interpretation
10.2.1.2.1. Cell Therapy Media Price Evaluation Matrix: Information on Volume of Media
10.2.1.2.2. Cell Therapy Media Price Evaluation Matrix: Information on Media Compatibility
10.2.1.2.3. Cell Therapy Media Price Evaluation Matrix: Information on Type of Product Manufacturing Practices
10.2.1.2.4. Cell Therapy Media Price Evaluation Matrix: Information on Application Area
10.2.1.2.5. Cell Therapy Media Price Evaluation Matrix: Information on Storage Temperature
10.2.1.2.6. Cell Therapy Media Price Evaluation Matrix: Information on Type of Cell Therapy
10.2.1.2.7. Cell Therapy Media Price Evaluation Matrix: Information on Type of Function
10.2.2. Theoretical Framework and Price Evaluation Hypothesis of Cell Therapy Extracellular Matrices
10.2.2.1. Methodology
10.2.2.2. Results and Interpretation
10.2.2.2.1. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Type of ECM Coating
10.2.2.2.2. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Type of Formulation
10.2.2.2.3. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Volume of Extracellular Matrices
10.2.2.2.4. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Storage Temperature
10.2.2.2.5. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Shelf Life
10.2.2.2.6. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Type of Stem Cell Therapy
10.2.2.2.7. Cell Therapy Extracellular Matrices Price Evaluation Matrix: Information on Type of Function

11. DEMAND ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Global Demand for Cell Therapy Consumables
11.3.1. Global Demand for Cell Therapy Consumables for Planar Processes
11.3.2. Global Demand for Cell Therapy Consumables for Suspension Processes
11.4. Analysis by Scale of Operation
11.5. Analysis by Geography

12. MARKET FORECAST AND OPPORTUNITY ANALYSIS
12.1. Chapter Overview
12.2. Key Assumptions and Methodology
12.3. Global Cell Therapy Consumables Market, 2023-2035

12.4. Cell Therapy Consumables Market: Analysis by Type of Product
12.4.1. Cell Therapy Consumables Market for Extracellular Matrices, 2023-2035
12.4.2. Cell Therapy Consumables Market for Kits, 2023-2035
12.4.3. Cell Therapy Consumables Market for Media, 2023-2035
12.4.4. Cell Therapy Consumables Market for Reagents, 2023-2035

12.5. Cell Therapy Consumables Market: Analysis by Type of Cell Therapy
12.5.1. Cell Therapy Consumables Market for Dendritic Cell Therapies, 2023-2035
12.5.2. Cell Therapy Consumables Market for NK Cell Therapies, 2023-2035
12.5.3. Cell Therapy Consumables Market for Stem Cell Therapies, 2023-2035
12.5.4. Cell Therapy Consumables Market for T-Cell Therapies, 2023-2035

12.6. Cell Therapy Consumables Market: Analysis by Scale of Operation
12.6.1. Cell Therapy Consumables Market for Clinical Operations, 2023-2035
12.6.2. Cell Therapy Consumables Market for Commercial Operations, 2023-2035

12.7. Cell Therapy Consumables Market: Analysis by Type of End-User
12.7.1. Cell Therapy Consumables Market for Industry Players, 2023-2035
12.7.2. Cell Therapy Consumables Market for Non-Industry Players, 2023-2035

12.8. Cell Therapy Consumables Market: Analysis by Geography
12.8.1. Cell Therapy Consumables Market in North America, 2023-2035
12.8.1.1. Cell Therapy Consumables Market in the US, 2023-2035
12.8.1.2. Cell Therapy Consumables Market in Canada, 2023-2035
12.8.1.3. Cell Therapy Consumables Market in Rest of North America, 2023-2035

12.8.2. Cell Therapy Consumables Market in Europe, 2023-2035
12.8.2.1. Cell Therapy Consumables Market in Spain, 2023-2035
12.8.2.2. Cell Therapy Consumables Market in France, 2023-2035
12.8.2.3. Cell Therapy Consumables Market in Germany, 2023-2035
12.8.2.4. Cell Therapy Consumables Market in Italy, 2023-2035
12.8.2.5. Cell Therapy Consumables Market in the Netherlands, 2023-2035
12.8.2.6. Cell Therapy Consumables Market in the UK, 2023-2035
12.8.2.7. Cell Therapy Consumables Market in Rest of Europe, 2023-2035

12.8.3. Cell Therapy Consumables Market in Asia-Pacific, 2023-2035
12.8.3.1. Cell Therapy Consumables Market in China, 2023-2035
12.8.3.2. Cell Therapy Consumables Market in Korea, 2023-2035
12.8.3.3. Cell Therapy Consumables Market in Rest of Asia-Pacific, 2023-2035

12.8.4. Cell Therapy Consumables Market in Middle East and North Africa, 2023-2035
12.8.5. Cell Therapy Consumables Market in Latin America, 2023-2035

13. UPCOMING TRENDS AND FUTURE GROWTH OPPORTUNITIES
13.1. Chapter Overview
13.2. Emerging Trends Related to Cell Culture Media
13.3. Automation of Cell Therapy Manufacturing Processes
13.4. Single Use Systems and Technologies in Cell Therapy Manufacturing

14. CONCLUDING REMARKS

15. INTERVIEW TRANSCRIPTS
15.1. Chapter Overview
15.2. Akadeum Life Sciences
15.2.1. Interview Transcript: Michael Maloney, Vice President of Business Development - Cell Therapy

15.3. Cellular Engineering Technologies
15.3.1. Interview Transcript: Anant Kamath, Chief Operating Officer

15.4. HiMedia Laboratories
15.4.1. Interview Transcript: Vishal G. Warke, Director R&D, Cell Culture and Immunology and Gauri W. Page, Assistant R&D Manager, Animal Cell Culture

16. APPENDIX I: TABULATED DATA

17. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures

Figure 2.1 Executive Summary: Market Landscape
Figure 2.2 Executive Summary: Recent Developments and Initiatives
Figure 2.3 Executive Summary: Demand Analysis
Figure 2.4 Executive Summary: Market Forecast and Opportunity Analysis
Figure 3.1 Types of Cell Therapy Consumables
Figure 4.1 Cell Therapy Consumables: Distribution by Type of Product
Figure 4.2 Cell Therapy Consumable Providers: Distribution by Company Size and Location of Headquarters
Figure 4.3 Cell Therapy Kit Providers: Distribution by Year of Establishment
Figure 4.4 Cell Therapy Kit Providers: Distribution by Company Size
Figure 4.5 Cell Therapy Kit Providers: Distribution by Location of Headquarters
Figure 4.6 Cell Therapy Kit Providers: Distribution by Location of Kit Manufacturing Facilities
Figure 4.7 Cell Therapy Kit Providers: Distribution by Certifications / Accreditations Received
Figure 4.8 Cell Therapy Kit Providers: Distribution by Type of End-User
Figure 4.9 Cell Therapy Kits: Distribution by Type of Cell Therapy
Figure 4.10 Cell Therapy Kits: Distribution by Type of Function
Figure 4.11 Cell Therapy Kits: Distribution by Kit Components
Figure 4.12 Cell Therapy Kits: Distribution by Storage Temperature
Figure 4.13 Cell Therapy Kits: Distribution by Scale of Operation
Figure 4.14 Cell Therapy Kits: Distribution by Application Area
Figure 4.15 Cell Therapy Kit Providers: Distribution by Application Area and Geography
Figure 4.16 Cell Therapy Media Providers: Distribution by Year of Establishment
Figure 4.17 Cell Therapy Media Providers: Distribution by Company Size
Figure 4.18 Cell Therapy Media Providers: Distribution by Location of Headquarters
Figure 4.19 Cell Therapy Media Providers: Distribution by Location of Media ManufacturingFacilities
Figure 4.20 Cell Therapy Media Providers: Distribution by Certifications / Accreditations Received
Figure 4.21 Cell Therapy Media Providers: Distribution by Type of End-User
Figure 4.22 Cell Therapy Media: Distribution by Type of Cell Therapy
Figure 4.23 Cell Therapy Media: Distribution by Media Compatibility
Figure 4.24 Cell Therapy Media: Distribution by Type of Function
Figure 4.25 Cell Therapy Media: Distribution by Storage Temperature
Figure 4.26 Cell Therapy Media: Distribution by Volume of Media
Figure 4.27 Cell Therapy Media: Distribution by Scale of Operation
Figure 4.28 Cell Therapy Media: Distribution by Application Area
Figure 4.29 Cell Therapy Media Providers: Distribution by Application Area and Geography
Figure 4.30 Cell Therapy Reagent Providers: Distribution by Year of Establishment
Figure 4.31 Cell Therapy Reagent Providers: Distribution by Company Size
Figure 4.32 Cell Therapy Reagent Providers: Distribution by Location of Headquarters
Figure 4.33 Cell Therapy Reagent Providers: Distribution by Location of Reagent Manufacturing Facilities
Figure 4.34 Cell Therapy Reagent Providers: Distribution by Certifications / Accreditations Received
Figure 4.35 Cell Therapy Reagent Providers: Distribution by Type of End-User
Figure 4.36 Cell Therapy Reagents: Distribution by Type of Cell Therapy
Figure 4.37 Cell Therapy Reagents: Distribution by Type of Function
Figure 4.38 Cell Therapy Reagents: Distribution by Storage Temperature
Figure 4.39 Cell Therapy Reagents: Distribution by Volume of Reagent
Figure 4.40 Cell Therapy Reagents: Distribution by Scale of Operation
Figure 4.41 Cell Therapy Reagents: Distribution by Application Area
Figure 4.42 Cell Therapy Reagent Providers: Distribution by Application Area and Geography
Figure 4.43 Cell Therapy Extracellular Matrix Providers: Distribution by Year of Establishment
Figure 4.44 Cell Therapy Extracellular Matrix Providers: Distribution by Company Size
Figure 4.45 Cell Therapy Extracellular Matrix Providers: Distribution by Location of Headquarters
Figure 4.46 Cell Therapy Extracellular Matrix Providers: Distribution by Location of Extracellular Matrix Manufacturing Facilities
Figure 4.47 Cell Therapy Extracellular Matrix Providers: Distribution by Certifications / Accreditations Received
Figure 4.48 Cell Therapy Extracellular Matrix Providers: Distribution by Type of End-User
Figure 4.49 Cell Therapy Extracellular Matrices: Distribution by Type of Stem Cell Therapy
Figure 4.50 Cell Therapy Extracellular Matrices: Distribution by Type of Function
Figure 4.51 Cell Therapy Extracellular Matrices: Distribution by Type of ECM Coating
Figure 4.52 Cell Therapy Extracellular Matrices: Distribution by Type of Formulation
Figure 4.53 Cell Therapy Extracellular Matrices: Distribution by Shelf Life
Figure 4.54 Cell Therapy Extracellular Matrices: Distribution by Storage Temperature
Figure 4.55 Cell Therapy Extracellular Matrices: Distribution by Volume of Extracellular Matrix
Figure 4.56 Cell Therapy Extracellular Matrices: Distribution by Scale of Operation
Figure 4.57 Cell Therapy Extracellular Matrices: Distribution by Application Area
Figure 4.58 Cell Therapy Extracellular Matrix Providers: Distribution by Application Area and Geography
Figure 5.1 Company Competitiveness Analysis: Cell Therapy Kit Providers
Figure 5.2 Company Competitiveness Analysis: Cell Therapy Media Providers based in North America
Figure 5.3 Company Competitiveness Analysis: Cell Therapy Media Providers based in Europe
Figure 5.4 Company Competitiveness Analysis: Cell Therapy Media Providers based in Asia-Pacific
Figure 5.5 Company Competitiveness Analysis: Cell Therapy Reagent Providers
Figure 5.6 Company Competitiveness Analysis: Cell Therapy Extracellular Matrix Providers
Figure 6.1 Brand Positioning Matrix: STEMCELL Technologies
Figure 6.2 Brand Positioning Matrix: Miltenyi Biotec
Figure 6.3 Brand Positioning Matrix: Thermo Fisher Scientific
Figure 6.4 Brand Positioning Matrix: Takara Bio
Figure 6.5 Brand Positioning Matrix: GeminiBio
Figure 7.1 STEMCELL Technologies: Product Portfolio
Figure 7.2 Miltenyi Biotec: Product Portfolio
Figure 7.3 Thermo Fisher Scientific: Product Portfolio
Figure 7.4 Bio-Techne: Product Portfolio
Figure 7.5 Irvine Scientific: Product Portfolio
Figure 7.6 Lonza: Product Portfolio
Figure 7.7 Sartorius: Product Portfolio
Figure 7.8 BD Biosciences: Product Portfolio
Figure 7.9 Corning: Product Portfolio
Figure 7.10 CellGenix: Product Portfolio
Figure 8.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2015-2022
Figure 8.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 8.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 8.4 Partnerships and Collaborations: Distribution by Type of Product
Figure 8.5 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Consumable
Figure 8.6 Partnerships and Collaborations: Distribution by Type of Cell Therapy
Figure 8.7 Partnerships and Collaborations: Distribution by Type of Product and Type of Cell Therapy
Figure 8.8 Most Active Players: Distribution by Number of Partnerships
Figure 8.9 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 8.10 Partnerships and Collaborations: Local and International Agreements
Figure 8.11 Mergers and Acquisitions: Cumulative Year-wise Trend, 2016-2022
Figure 8.12 Mergers and Acquisitions: Distribution by Type of Agreement
Figure 8.13 Mergers and Acquisitions: Distribution by Key Value Drivers
Figure 8.14 Mergers and Acquisitions: Distribution by Year of Acquisition and Key Value Drivers
Figure 8.15 Recent Expansions: Cumulative Year-wise Trend, 2017-2022
Figure 8.16 Recent Expansions: Distribution by Type of Expansion
Figure 8.17 Recent Expansions: Distribution by Year and Type of Expansion
Figure 8.18 Recent Expansions: Distribution by Type of Product
Figure 8.19 Recent Expansions: Distribution by Type of Expansion and Type of Consumable
Figure 8.20 Recent Expansions: Distribution by Area of Expansion (Sq. Ft.)
Figure 8.21 Most Active Players: Distribution by Number of Expansions
Figure 8.22 Recent Expansions: Distribution by Location of Facility (Continent-wise)
Figure 8.23 Recent Expansions: Distribution by Location of Facility (Country-wise)
Figure 8.24 Recent Expansions: Distribution by Type of Expansion and Location of Facility
Figure 10.1 Cell Therapy Media: Roots Analysis Pricing Strategy Matrix
Figure 10.2 Cell Therapy Media: Roots Analysis Pricing Strategy Graphical Interpretation
Figure 10.3 Cell Therapy Extracellular Matrices: Roots Analysis Pricing Strategy Matrix
Figure 10.4 Cell Therapy Extracellular Matrices: Roots Analysis Pricing Strategy Graphical Interpretation
Figure 11.1 Global Demand for Cell Therapy Consumables, 2023-2035 (Thousand Liters)
Figure 11.2 Global Demand for Cell Therapy Consumables for Planar Process, 2023-2035 (Thousand Liters)
Figure 11.3 Global Demand for Cell Therapy Consumables for Suspension Process, 2023-2035 (Thousand Liters)
Figure 11.4 Global Demand for Cell Therapy Consumables for Planar Process, 2023-2035: Distribution by Scale of Operation (Thousand Liters)
Figure 11.5 Global Demand for Cell Therapy Consumables for Suspension Process, 2023-2035: Distribution by Scale of Operation (Thousand Liters)
Figure 11.6 Global Demand for Cell Therapy Consumables: Distribution by Geography, 2023 and 2035
Figure 11.7 Global Demand for Cell Therapy Consumables for Planar Process, 2023-2035: Distribution by Geography (Thousand Liters)
Figure 11.8 Global Demand for Cell Therapy Consumables for Suspension Process, 2023-2035: Distribution by Geography (Thousand Liters)
Figure 12.1 Global Cell Therapy Consumables Market, 2023-2035 (USD Million)
Figure 12.2 Cell Therapy Consumables Market: Distribution by Type of Product, 2023 and 2035
Figure 12.3 Cell Therapy Consumables Market for Extracellular Matrices, 2023-2035 (USD Million)
Figure 12.4 Cell Therapy Consumables Market for Kits, 2023-2035 (USD Million)
Figure 12.5 Cell Therapy Consumables Market for Media, 2023-2035 (USD Million)
Figure 12.6 Cell Therapy Consumables Market for Reagents, 2023-2035 (USD Million)
Figure 12.7 Cell Therapy Consumables Market: Distribution by Type of Cell Therapy, 2023, 2028 and 2035
Figure 12.8 Cell Therapy Consumables Market for Dendritic Cell Therapies, 2023-2035 (USD Million)
Figure 12.9 Cell Therapy Consumables Market for NK Cell Therapies, 2023-2035 (USD Million)
Figure 12.10 Cell Therapy Consumables Market for Stem Cell Therapies, 2023-2035 (USD Million)
Figure 12.11 Cell Therapy Consumables Market for T-Cell Therapies, 2023-2035 (USD Million)
Figure 12.12 Cell Therapy Consumables Market: Distribution by Scale of Operation, 2023 and 2035
Figure 12.13 Cell Therapy Consumables Market for Clinical Operations, 2023-2035 (USD Million)
Figure 12.14 Cell Therapy Consumables Market for Commercial Operations, 2023-2035 (USD Million)
Figure 12.15 Cell Therapy Consumables Market: Distribution by Type of End-User, 2023 and 2035
Figure 12.16 Cell Therapy Consumables Market for Industry Players, 2023-2035 (USD Million)
Figure 12.17 Cell Therapy Consumables Market for Non-Industry Players, 2023-2035 (USD Million)
Figure 12.18 Cell Therapy Consumables Market: Distribution by Geography, 2023 and 2035
Figure 12.19 Cell Therapy Consumables Market in North America, 2023-2035 (USD Million)
Figure 12.20 Cell Therapy Consumables Market in the US, 2023-2035 (USD Million)
Figure 12.21 Cell Therapy Consumables Market in Canada, 2023-2035 (USD Million)
Figure 12.22 Cell Therapy Consumables Market in Rest of North America, 2023-2035 (USD Million)
Figure 12.23 Cell Therapy Consumables Market in Europe, 2023-2035 (USD Million)
Figure 12.24 Cell Therapy Consumables Market in Spain, 2023-2035 (USD Million)
Figure 12.25 Cell Therapy Consumables Market in France, 2023-2035 (USD Million)
Figure 12.26 Cell Therapy Consumables Market in Germany, 2023-2035 (USD Million)
Figure 12.27 Cell Therapy Consumables Market in Italy, 2023-2035 (USD Million)
Figure 12.28 Cell Therapy Consumables Market in the Netherlands, 2023-2035 (USD Million)
Figure 12.29 Cell Therapy Consumables Market in the UK, 2023-2035 (USD Million)
Figure 12.30 Cell Therapy Consumables Market in Rest of Europe, 2023-2035 (USD Million)
Figure 12.31 Cell Therapy Consumables Market in Asia-Pacific, 2023-2035 (USD Million)
Figure 12.32 Cell Therapy Consumables Market in China, 2023-2035 (USD Million)
Figure 12.33 Cell Therapy Consumables Market in Korea, 2023-2035 (USD Million)
Figure 12.34 Cell Therapy Consumables Market in Rest of Asia-Pacific, 2023-2035 (USD Million)
Figure 12.35 Cell Therapy Consumables Market in Middle East and North Africa, 2023-2035 (USD Million)
Figure 12.36 Cell Therapy Consumables Market in Latin America, 2023-2035 (USD Million)
Figure 14.1 Concluding Remarks: Overall Market Landscape
Figure 14.2 Concluding Remarks: Recent Developments
Figure 14.3 Concluding Remarks: Demand Analysis
Figure 14.4 Concluding Remarks: Market Forecast and Opportunity Analysis
Figure 14.5 Concluding Remarks: Market Forecast and Opportunity Analysis

List Of Tables

Table 3.1 Cell Therapies: Applications
Table 3.2 Differences between Cell Therapies and Other Biopharmaceuticals
Table 3.3 Key Cell Therapy Manufacturing Steps
Table 3.4 Types of Media Used in Cell Therapy Manufacturing
Table 4.1 List of Cell Therapy Kit Providers
Table 4.2 Cell Therapy Kits: Information on Type of Cell Therapy and Type of Function
Table 4.3 Cell Therapy Kits: Information on Kit Components and Storage Temperature
Table 4.4 Cell Therapy Kits: Information on Scale of Operation and Application Area
Table 4.5 List of Cell Therapy Media Providers
Table 4.6 Cell Therapy Media: Information on Type of Cell Therapy, Media Compatibility and Type of Function
Table 4.7 Cell Therapy Media: Information on Storage Temperature and Volume of Media
Table 4.8 Cell Therapy Media: Information on Scale of Operation and Application Area
Table 4.9 List of Cell Therapy Reagent Providers
Table 4.10 Cell Therapy Reagents: Information on Type of Cell Therapy and Type of Function
Table 4.11 Cell Therapy Reagents: Information on Storage Temperature and Volume of Reagent
Table 4.12 Cell Therapy Reagents: Information on Scale of Operation and Application Area
Table 4.13 List of Cell Therapy Extracellular Matrix Providers
Table 4.14 Cell Therapy Extracellular Matrices: Information on Type of Stem Cell Therapy and Type of Function
Table 4.15 Cell Therapy Extracellular Matrices: Information on Type of ECM Coating and Type of Formulation
Table 4.16 Cell Therapy Extracellular Matrices: Information on Shelf Life, Storage Temperature and Volume of Extracellular Matrix
Table 4.17 Cell Therapy Extracellular Matrices: Information on Scale of Operation and Application Area
Table 7.1 STEMCELL Technologies: Company Overview
Table 7.2 STEMCELL Technologies: Recent Developments and Future Outlook
Table 7.3 Miltenyi Biotec: Company Overview
Table 7.4 Miltenyi Biotec: Recent Developments and Future Outlook
Table 7.5 Thermo Fisher Scientific: Company Overview
Table 7.6 Thermo Fisher Scientific: Recent Developments and Future Outlook
Table 7.7 Bio-Techne: Company Overview
Table 7.8 Bio-Techne: Recent Developments and Future Outlook
Table 7.9 Irvine Scientific: Company Overview
Table 7.10 Irvine Scientific: Recent Developments and Future Outlook
Table 7.11 Lonza: Company Overview
Table 7.12 Sartorius: Company Overview
Table 7.13 Sartorius: Recent Developments and Future Outlook
Table 7.14 BD Biosciences: Company Overview
Table 7.15 BD Biosciences: Recent Developments and Future Outlook
Table 7.16 Corning: Company Overview
Table 7.17 CellGenix: Company Overview
Table 7.18 CellGenix: Recent Developments and Future Outlook
Table 8.1 Cell Therapy Consumables: List of Partnerships and Collaborations, 2015-2022
Table 8.2 Cell Therapy Consumables: Information on Location of Headquarters, 2015-2022
Table 8.3 Mergers and Acquisitions: List of Mergers and Acquisitions, 2016-2022
Table 8.4 Mergers and Acquisitions: Information on Key Value Drivers, 2016-2022
Table 8.5 Cell Therapy Consumables: List of Recent Expansions, 2017-2022
Table 9.1 Key Potential Strategic Partners for Cell Therapy Consumable Providers
Table 9.2 Likely Partners for Dendritic Cell Therapy Consumable Providers
Table 9.3 Likely Partners for NK Cell Therapy Consumable Providers
Table 9.4 Likely Partners for Stem Cell Therapy Consumable Providers
Table 9.5 Likely Partners for T-Cell Therapy Consumable Providers
Table 10.1 Media Price Evaluation Matrix: Based on Volume of Media
Table 10.2 Media Price Evaluation Matrix: Based on Media Compatibility
Table 10.3 Media Price Evaluation Matrix: Based on Type of Product Manufacturing Practices
Table 10.4 Media Price Evaluation Matrix: Based on Application Area
Table 10.5 Media Price Evaluation Matrix: Based on Storage Temperature
Table 10.6 Media Price Evaluation Matrix: Based on Type of Cell Therapy
Table 10.7 Media Price Evaluation Matrix: Based on Type of Function
Table 10.8 ECM Price Evaluation Matrix: Based on Type of ECM Coating
Table 10.9 ECM Price Evaluation Matrix: Based on Type of Formulation
Table 10.10 ECM Price Evaluation Matrix: Based on Volume of Extracellular Matrix
Table 10.11 ECM Price Evaluation Matrix: Based on Storage Temperature
Table 10.12 ECM Price Evaluation Matrix: Based on Shelf Life
Table 10.13 ECM Price Evaluation Matrix: Based on Type of Stem Cell Therapy
Table 10.14 ECM Price Evaluation Matrix: Based on Type of Function
Table 15.1 Akadeum Life Sciences: Key Highlights
Table 15.2 Cellular Engineering Technologies: Key Highlights
Table 15.3 HiMedia Laboratories: Key Highlights
Table 16.1 Cell Therapy Consumables: Distribution by Type of Product
Table 16.2 Cell Therapy Consumable Providers: Distribution by Company Size and Location of Headquarters
Table 16.3 Cell Therapy Kit Providers: Distribution by Year of Establishment
Table 16.4 Cell Therapy Kit Providers: Distribution by Company Size
Table 16.5 Cell Therapy Kit Providers: Distribution by Location of Headquarters
Table 16.6 Cell Therapy Kit Providers: Distribution by Location of Kit Manufacturing Facilities
Table 16.7 Cell Therapy Kit Providers: Distribution by Certifications / Accreditations Received
Table 16.8 Cell Therapy Kit Providers: Distribution by Type of End-User
Table 16.9 Cell Therapy Kits: Distribution by Type of Cell Therapy
Table 16.10 Cell Therapy Kits: Distribution by Type of Function
Table 16.11 Cell Therapy Kits: Distribution by Kit Components
Table 16.12 Cell Therapy Kits: Distribution by Storage Temperature
Table 16.13 Cell Therapy Kits: Distribution by Scale of Operation
Table 16.14 Cell Therapy Kits: Distribution by Application Area
Table 16.15 Cell Therapy Media Providers: Distribution by Year of Establishment
Table 16.16 Cell Therapy Media Providers: Distribution by Company Size
Table 16.17 Cell Therapy Media Providers: Distribution by Location of Headquarters
Table 16.18 Cell Therapy Media Providers: Distribution by Location of Media Manufacturing Facilities
Table 16.19 Cell Therapy Media Providers: Distribution by Certifications / Accreditations Received
Table 16.20 Cell Therapy Media Providers: Distribution by Type of End-User
Table 16.21 Cell Therapy Media: Distribution by Type of Cell Therapy
Table 16.22 Cell Therapy Media: Distribution by Media Compatibility
Table 16.23 Cell Therapy Media: Distribution by Type of Function
Table 16.24 Cell Therapy Media: Distribution by Storage Temperature
Table 16.25 Cell Therapy Media: Distribution by Volume of Media
Table 16.26 Cell Therapy Media: Distribution by Scale of Operation
Table 16.27 Cell Therapy Media: Distribution by Application Area
Table 16.28 Cell Therapy Reagent Providers: Distribution by Year of Establishment
Table 16.29 Cell Therapy Reagent Providers: Distribution by Company Size
Table 16.30 Cell Therapy Reagent Providers: Distribution by Location of Headquarters
Table 16.31 Cell Therapy Reagent Providers: Distribution by Location of Reagent Manufacturing Facilities
Table 16.32 Cell Therapy Reagent Providers: Distribution by Certifications / Accreditations Received
Table 16.33 Cell Therapy Reagent Providers: Distribution by Type of End-User
Table 16.34 Cell Therapy Reagents: Distribution by Type of Cell Therapy
Table 16.35 Cell Therapy Reagents: Distribution by Type of Function
Table 16.36 Cell Therapy Reagents: Distribution by Storage Temperature
Table 16.37 Cell Therapy Reagents: Distribution by Volume of Reagent
Table 16.38 Cell Therapy Reagents: Distribution by Scale of Operation
Table 16.39 Cell Therapy Reagents: Distribution by Application Area
Table 16.40 Cell Therapy Extracellular Matrix Providers: Distribution by Year of Establishment
Table 16.41 Cell Therapy Extracellular Matrix Providers: Distribution by Company Size
Table 16.42 Cell Therapy Extracellular Matrix Providers: Distribution by Location of Headquarters
Table 16.43 Cell Therapy Extracellular Matrix Providers: Distribution by Location of Extracellular Matrix Manufacturing Facilities
Table 16.44 Cell Therapy Extracellular Matrix Providers: Distribution by Certifications / Accreditations Received
Table 16.45 Cell Therapy Extracellular Matrix Providers: Distribution by Type of End-User
Table 16.46 Cell Therapy Extracellular Matrices: Distribution by Type of Stem Cell Therapy
Table 16.47 Cell Therapy Extracellular Matrices: Distribution by Type of Function
Table 16.48 Cell Therapy Extracellular Matrices: Distribution by Type of ECM Coating
Table 16.49 Cell Therapy Extracellular Matrices: Distribution by Type of Formulation
Table 16.50 Cell Therapy Extracellular Matrices: Distribution by Shelf Life
Table 16.51 Cell Therapy Extracellular Matrices: Distribution by Storage Temperature
Table 16.52 Cell Therapy Extracellular Matrices: Distribution by Volume of Extracellular Matrix
Table 16.53 Cell Therapy Extracellular Matrices: Distribution by Scale of Operation
Table 16.54 Cell Therapy Extracellular Matrices: Distribution by Application Area
Table 16.55 Partnerships and Collaborations: Cumulative Year-wise Trend, 2015-2022
Table 16.56 Partnerships and Collaborations: Distribution by Type of Partnership
Table 16.57 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partnership, 2015-2022
Table 16.58 Partnerships and Collaborations: Distribution by Type of Product
Table 16.59 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Consumable
Table 16.60 Partnerships and Collaborations: Distribution by Type of Cell Therapy
Table 16.61 Partnerships and Collaborations: Distribution by Type of Product and Type of Cell Therapy
Table 16.62 Most Active Players: Distribution by Number of Partnerships
Table 16.63 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 16.64 Partnerships and Collaborations: Local and International Agreements
Table 16.65 Mergers and Acquisitions: Cumulative Year-wise Trend, 2016-2022
Table 16.66 Mergers and Acquisitions: Distribution by Type of Agreement
Table 16.67 Mergers and Acquisitions: Distribution by Key Value Drivers
Table 16.68 Mergers and Acquisitions: Distribution by Year of Acquisition and Key Value Drivers, 2016-2022
Table 16.69 Recent Expansions: Cumulative Year-wise Trend, 2017-2022
Table 16.70 Recent Expansions: Distribution by Type of Expansion
Table 16.71 Recent Expansions: Distribution by Year and Type of Expansion, 2017-2022
Table 16.72 Recent Expansions: Distribution by Type of Product
Table 16.73 Recent Expansions: Distribution by Type of Expansion and Type of Product
Table 16.74 Recent Expansions: Distribution by Area of Expansion
Table 16.75 Most Active Players: Distribution by Number of Expansions
Table 16.76 Recent Expansions: Distribution by Location of Facility (Continent-wise)
Table 16.77 Recent Expansions: Distribution by Location of Facility (Country-wise)
Table 16.78 Recent Expansions: Distribution by Type of Expansion and Location of Facility
Table 16.79 Global Demand for Cell Therapy Consumables, 2023-2035 (Thousand Liters)
Table 16.80 Global Demand for Cell Therapy Consumables for Planar Process, 2023-2035 (Thousand Liters)
Table 16.81 Global Demand for Cell Therapy Consumables for Suspension Process, 2023-2035 (Thousand Liters)
Table 16.82 Global Demand for Cell Therapy Consumables for Planar Process, 2023-2035: Distribution by Scale of Operation (Thousand Liters)
Table 16.83 Global Demand for Cell Therapy Consumables for Suspension Process, 2023-2035: Distribution by Scale of Operation (Thousand Liters)
Table 16.84 Global Demand for Cell Therapy Consumables: Distribution by Geography, 2023 and 2035
Table 16.85 Global Demand for Cell Therapy Consumables for Planar Process, 2023-2035: Distribution by Geography (Thousand Liters)
Table 16.86 Global Demand for Cell Therapy Consumables for Suspension Process, 2023-2035: Distribution by Geography (Thousand Liters)
Table 16.87 Global Cell Therapy Consumables Market, 2023-2035 (USD Million)
Table 16.88 Cell Therapy Consumables Market: Distribution by Type of Product, 2023 and 2035
Table 16.89 Cell Therapy Consumables Market for Extracellular Matrices, 2023-2035 (USD Million)
Table 16.90 Cell Therapy Consumables Market for Kits, 2023-2035 (USD Million)
Table 16.91 Cell Therapy Consumables Market for Media, 2023-2035 (USD Million)
Table 16.92 Cell Therapy Consumables Market for Reagents, 2023-2035 (USD Million)
Table 16.93 Cell Therapy Consumables Market: Distribution by Type of Cell Therapy, 2023, 2028 and 2035
Table 16.94 Cell Therapy Consumables Market for Dendritic Cell Therapies, 2023-2035 (USD Million)
Table 16.95 Cell Therapy Consumables Market for NK Cell Therapies, 2023-2035 (USD Million)
Table 16.96 Cell Therapy Consumables Market for Stem Cell Therapies, 2023-2035 (USD Million)
Table 16.97 Cell Therapy Consumables Market for T-Cell Therapies, 2023-2035 (USD Million)
Table 16.98 Cell Therapy Consumables Market: Distribution by Scale of Operation, 2023 and 2035
Table 16.99 Cell Therapy Consumables Market for Clinical Operations, 2023-2035 (USD Million)
Table 16.100 Cell Therapy Consumables Market for Commercial Operations, 2023-2035 (USD Million)
Table 16.101 Cell Therapy Consumables Market: Distribution by Type of End-User, 2023 and 2035
Table 16.102 Cell Therapy Consumables Market for Industry Players, 2023-2035 (USD Million)
Table 16.103 Cell Therapy Consumables Market for Non-Industry Players, 2023-2035 (USD Million)
Table 16.104 Cell Therapy Consumables Market: Distribution by Geography, 2023 and 2035
Table 16.105 Cell Therapy Consumables Market in North America, 2023-2035 (USD Million)
Table 16.106 Cell Therapy Consumables Market in the US, 2023-2035 (USD Million)
Table 16.107 Cell Therapy Consumables Market in Canada, 2023-2035 (USD Million)
Table 16.108 Cell Therapy Consumables Market in Rest of North America, 2023-2035 (USD Million)
Table 16.109 Cell Therapy Consumables Market in Europe, 2023-2035 (USD Million)
Table 16.110 Cell Therapy Consumables Market in Spain, 2023-2035 (USD Million)
Table 16.111 Cell Therapy Consumables Market in France, 2023-2035 (USD Million)
Table 16.112 Cell Therapy Consumables Market in Germany, 2023-2035 (USD Million)
Table 16.113 Cell Therapy Consumables Market in Italy, 2023-2035 (USD Million)
Table 16.114 Cell Therapy Consumables Market in the Netherlands, 2023-2035 (USD Million)
Table 16.115 Cell Therapy Consumables Market in the UK, 2023-2035 (USD Million)
Table 16.116 Cell Therapy Consumables Market in Rest of Europe, 2023-2035 (USD Million)
Table 16.117 Cell Therapy Consumables Market in Asia-Pacific, 2023-2035 (USD Million)
Table 16.118 Cell Therapy Consumables Market in China, 2023-2035 (USD Million)
Table 16.119 Cell Therapy Consumables Market in Korea, 2023-2035 (USD Million)
Table 16.120 Cell Therapy Consumables Market in Rest of Asia-Pacific, 2023-2035 (USD Million)
Table 16.121 Cell Therapy Consumables Market in Middle East and North Africa, 2023-2035 (USD Million)
Table 16.122 Cell Therapy Consumables Market in Latin America, 2023-2035 (USD Million)

List Of Companies

The following companies and organizations have been mentioned in the report:

1. Accellta
2. Acer Therapeutics
3. ACROBiosystems
4. Activartis Biotech
5. AddLife
6. Adicet Bio
7. Aduro Biotech
8. Advanced BioMatrix (Acquired by BICO)
9. Advent Bioservices
10. AGC Biologics
11. AgenTus Therapeutics
12. Agilent Technologies
13. Ajinomoto
14. Akadeum Life Sciences
15. Akron Biotech
16. Allele Biotechnology and Pharmaceuticals
17. Allife Medical Science and Technology
18. Allogene Therapeutics
19. Altor BioScience
20. American CryoStem
21. Amphera
22. AMSBIO
23. ANI Pharmaceuticals
24. apceth Biopharma
25. Applied Biological Materials
26. Applied Cells
27. Arbele
28. Arcline Investment Management
29. Argos Therapeutics
30. Aspire Health Science
31. Asterias Biotherapeutics
32. ATCC
33. Athersys
34. Atlantis Bioscience
35. Atreca
36. Aurora Biopharma
37. Austrianova
38. Autolus
39. Avantor
40. AVAX Technologies
41. Axion BioSystems
42. Axol Bioscience
43. Basic Pharma
44. BD Biosciences
45. Beijing Biohealthcare Biotechnology
46. Beijing Doing Biomedical
47. Beijing Immunochina Medical Science & Technology
48. Beijing Sanwater Biological Technology
49. Beijing Tricision Biotherapeutics 
50. Bellicum Pharmaceuticals
51. Bio Elpida
52. BioAtla
53. BioCardia
54. BioCare
55. BioCentriq
56. Bio-Connect
57. BioInno Bioscience
58. Bioinova
59. Biological Industries
60. BioRestorative Therapies
61. Bio-Techne 
62. Biowest
63. Bone Therapeutics
64. BrainStorm Cell Therapeutics
65. Brigham and Women’s Hospital
66. C3i (Center of Excellence for Cellular Therapy)
67. Caladrius Biosciences
68. Capricor Therapeutics
69. Captain T Cell
70. Captivate Bio
71. CardioCell
72. Carina Biotech
73. CARsgen Therapeutics
74. CAR-T (Shanghai) Biotechnology
75. Cartherics
76. Celixir
77. Cell and Gene Therapy Catapult
78. Cell Applications
79. Cell Biologics
80. Cell Biotech
81. Cell Culture Technologies
82. Cell Systems
83. Cell Therapies
84. Cell-Easy
85. Cellectis
86. CellGenix
87. Cellin Technologies
88. Cellmed
89. CellMP (A subsidiary of Emmecell)
90. CELLnTEC Advanced Cell Systems
91. CellPraxis
92. CellProtect Nordic Pharmaceuticals
93. CellProthera
94. Cells for Cells 
95. Cells Online
96. CellSystems
97. Cellular Biomedicine Group
98. Cellular Engineering Technologies
99. Cellular Therapeutics
100. Celprogen
101. Celularity
102. Celyad
103. Censo Biotechnologies
104. CHA Biolab
105. Chengdu MedGenCell
106. CiMaas
107. Cincinnati Children’s Hospital Medical Center
108. Clean Cells
109. CO.DON
110. Cogent Biosciences
111. Cognate BioServices
112. CoImmune
113. CollPlant
114. Cook MyoSite
115. Corestem
116. Corning
117. Creative Bioarray
118. Creative Biolabs
119. CRISPR Therapeutics
120. Cyagen
121. Cytiva
122. Cytopeutics
123. CytoSen Therapeutics (Acquired by Kiadis Pharma)
124. Cytovac
125. CyTuVax 
126. DanDrit Biotech
127. DCPrime
128. Delta-Vir
129. denovoMATRIX
130. DiscGenics
131. ElevateBio
132. Endocyte
133. Eureka Therapeutics
134. Eutilex
135. EXUMA Biotech
136. Fate Therapeutics
137. Fibrocell Technologies
138. Five Prime Therapeutics
139. Formula Pharmaceuticals
140. Fortress Biotech
141. Froceth
142. FroggaBio
143. FUJIFILM Cellular Dynamics
144. FUJIFILM Wako Pure Chemicals
145. Gadeta
146. Gamida Cell
147. GE Healthcare
148. GeminiBio
149. GenCure
150. GenCure (A subsidiary of BioBridge Global)
151. GenIbet Biopharmaceuticals
152. GigaGen 
153. Global Cell Med
154. Glycostem Therapeutics
155. Gradalis
156. GRI Bio
157. Guangzhou Trinomab Biotech
158. Heat Biologics
159. Hebei Senlang Biotechnology
160. Hemostemix
161. HengRui YuanZheng Bio-Technology
162. HiMedia Laboratories
163. Histocell
164. Histogenics
165. Hitachi Chemical
166. Holostem Terapie Avanzate
167. Hunan Zhaotai Yongren Biotech
168. IBA Lifesciences
169. iCarTAB BioMed
170. iCell Gene Therapeutics
171. Immatics
172. Immune Therapeutics
173. Immunicum
174. ImmunoCellular Therapeutics
175. Immunovative Therapies 
176. Immutep
177. IncoCell Tianjin (A subsidiary of Boyalife)
178. Incysus
179. Innoprot
180. Innovative Cellular Therapeutics
181. inRegen
182. International Stem Cell Corporation
183. InVitria
184. Iovance Biotherapeutics
185. Irvine Scientific (Acquired by FUJIFILM)
186. ISTO Technologies
187. Ivy Life Sciences
188. iXCells Biotechnologies
189. Japan Tissue Engineering
190. JSR 
191. JW Biotechnology
192. JW CreaGene
193. Kadimastem
194. Kangstem Biotech
195. Kiadis Pharma
196. Kiromic
197. Kuur Therapeutics
198. LAgen Laboratories
199. Laurus Labs
200. Laurus Bio
201. Leucid Bio
202. Life Technologies
203. Lifecells
204. Lifeline Cell Technology
205. Lineage Cell Therapeutics
206. Lion TCR
207. Living Pharma
208. Longeveron
209. Lonza
210. Lumos Pharma
211. Lyell Immunopharma
212. Lykan Bioscience
213. Marino Biotechnology
214. Matrixome
215. MaxCyte
216. MBL Beijing Biotech
217. Medeor Therapeutics
218. MEDianus Pharma
219. Medigene
220. MEDINET
221. MedVax Technologies
222. Mesoblast
223. Metrion Biosciences
224. Miltenyi Biotech
225. Minerva Biotechnologies
226. Minovia Therapeutics
227. MolecuVax
228. Moraga Biotechnology
229. MultiClonal Therapeutics
230. Multimmune
231. Multus Biotechnology
232. Mustang Bio 
233. Nanjing KAEDI Biotechnology
234. NantKwest
235. NeuCyte
236. Neuralstem
237. Neuromics
238. Nikon CeLL innovation
239. Nkarta
240. Nohla Therapeutics
241. Noile-Immune Biotech
242. Northern Therapeutics
243. Northwest Biotherapeutics
244. Novadip Biosciences
245. NovaRx (Acquired by Viropro)
246. Novex Innovations
247. Nucleus Biologics
248. Nuo Therapeutics
249. Octapharma
250. OiDE BetaRevive
251. Ology Bioservices
252. Omni Lifesciences
253. Oncobiomed
254. Opexa Therapeutics
255. Orchard Therapeutics
256. OrganaBio
257. Ori Biotech
258. Pall Corporation
259. PAN-Biotech
260. PBS Biotech
261. PDC*line Pharma
262. PELOBiotech
263. PeproTech
264. PersonGen BioTherapeutics
265. PharmaBio
266. Pharmicell
267. PhoenixSongs Biologicals
268. Pinze Lifetechnology
269. Pique Therapeutics
270. Pluristem Therapeutics
271. Plus Therapeutics
272. Poseida Therapeutics
273. Precision BioSciences
274. Preferred Cell Systems™
275. Pregene ShenZhen Biotechnology
276. Primorigen Biosciences (Acquired by Nucleus Biologics)
277. ProMab Biotechnologies
278. Promethera Biosciences
279. PromoCell
280. Propagenix
281. Provia Laboratories
282. R&D Systems
283. ReachBio Research Labs
284. Regeneris Medical
285. Regeneus
286. ReNeuron
287. REPROCELL
288. Rexgenero
289. RHEACELL
290. Riyadh Pharma
291. ROKIT Healthcare
292. RoosterBio
293. Roslin Cell Therapies
294. Rousselot Biomedical
295. Rubius Therapeutics
296. S.Biomedics
297. Sangamo Therapeutics
298. Sanvitra
299. Saronic Biotechnology
300. Sartorius
301. Sartorius Korea Biotech (A subsidiary of Sartorius)
302. Sartorius Stedim Biotech
303. ScienCell Research Laboratories
304. Scinogy
305. Sclnow Biotechnology
306. SCM Lifescience
307. Sentien Biotechnologies
308. Shanghai Bioray Laboratory
309. Shanghai Houchao Biotechnology
310. Shanghai iCELL Biotechnology
311. Shanghai Longyao Biotechnology
312. Shanghai Unicar-Therapy Bio-medicine Technology
313. Shenzhen BinDeBio
314. Shenzhen Hornetcorn Biotechnology
315. Sigma-Aldrich
316. Sinobioway Cell Therapy
317. SMT Bio
318. Sorrento Therapeutics
319. SQZ Biotechnologies
320. Stem Cell Arabia
321. STEMCELL Technologies
322. StemImmune
323. Stemmatters 
324. Super-T Cell Cancer Company
325. Surface Oncology
326. Tactiva Therapeutics
327. Taiwan Bio Therapeutics
328. Takara Bio
329. TapImmune 
330. Targazyme
331. TC BioPharm
332. TCR2 Therapeutics
333. Tella
334. Tessa Therapeutics
335. The Discovery Labs Center for Breakthrough Medicines
336. Thermo Fisher Scientific
337. ThermoGenesis
338. Tianhe Stem Cell Biotechnologies
339. Tianjin Ever Union Biotechnology 
340. TiGenix
341. TILT Biotherapeutics
342. Tmunity Therapeutics
343. TNK Therapeutics
344. TotipotentRX
345. TRACT Therapeutics
346. TransCure BioServices
347. TransGen Biotech
348. TreeFrog Therapeutics
349. TRINOVA BIOCHEM
350. Triumvira Immunologics
351. TVAX Biomedical
352. U.S. Stem Cell
353. United States Biological
354. Universal Cells
355. Vaccinogen
356. Vericel
357. VetStem Biopharma
358. Vinasets
359. ViroMed
360. Viscofan BioEngineering
361. Vitro Biopharma
362. Vivo Bio Tech
363. Waisman Biomanufacturing
364. West Biotherapy
365. WiCell
366. Wissenschaftlicher Service Pharma (WiSP)
367. Worchester Polytechnic Institute
368. Wuhan Sian Medical Technology
369. Xcell Therapeutics
370. Xcelthera
371. XEME Biopharma
372. ZellBio
373. Zelluna Immunotherapy
374. Ziopharm Oncology

Source 1: https://www.thermofisher.com/blog/behindthebench/raw-material-considerations-cell-therapy/
Source 2: https://www.cellandgene.com/doc/cell-gene-therapies-investment-outlook-in-beyond-0001